中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

114 records (took 0.02 seconds)

    Adaptable framework for cloud assisted augmented reality
    51.
    发明授权
    Adaptable framework for cloud assisted augmented reality 有权
    适用于云辅助增强现实的框架

    公开(公告)号：US09495760B2

    公开(公告)日：2016-11-15

    申请号：US13235847

    申请日：2011-09-19

    Applicant: Ashwin Swaminathan ,  Piyush Sharma ,  Bolan Jiang ,  Murali R. Chari ,  Serafin Diaz Spindola ,  Pawan Kumar Baheti ,  Vidya Narayanan

    Inventor： Ashwin Swaminathan ,  Piyush Sharma ,  Bolan Jiang ,  Murali R. Chari ,  Serafin Diaz Spindola ,  Pawan Kumar Baheti ,  Vidya Narayanan

    IPC: G06K9/00 ,  G06T7/20 ,  G06T7/00

    CPC classification number: G06T7/246 ,  G06K9/00671 ,  G06T7/73 ,  G06T2207/10004

    Abstract: A mobile platform efficiently processes sensor data, including image data, using distributed processing in which latency sensitive operations are performed on the mobile platform, while latency insensitive, but computationally intensive operations are performed on a remote server. The mobile platform acquires sensor data, such as image data, and determines whether there is a trigger event to transmit the sensor data to the server. The trigger event may be a change in the sensor data relative to previously acquired sensor data, e.g., a scene change in an image. When a change is present, the sensor data may be transmitted to the server for processing. The server processes the sensor data and returns information related to the sensor data, such as identification of an object in an image or a reference image or model. The mobile platform may then perform reference based tracking using the identified object or reference image or model.

    Abstract translation: 移动平台使用在移动平台上执行延迟敏感操作的分布式处理来有效地处理包括图像数据的传感器数据，而延迟不敏感，但在远程服务器上执行计算密集型操作。 移动平台获取诸如图像数据的传感器数据，并且确定是否存在将传感器数据传送到服务器的触发事件。 触发事件可以是传感器数据相对于先前获取的传感器数据的变化，例如图像中的场景变化。 当存在变化时，传感器数据可以被发送到服务器进行处理。 服务器处理传感器数据并返回与传感器数据相关的信息，例如图像中的对象或参考图像或模型的识别。 然后，移动平台可以使用所识别的对象或参考图像或模型来执行基于参考的跟踪。

    SYSTEM AND METHOD FOR DAY-ZERO AUTHENTICATION OF ACTIVEX CONTROLS
    55.
    发明申请
    SYSTEM AND METHOD FOR DAY-ZERO AUTHENTICATION OF ACTIVEX CONTROLS 审中-公开
    用于ActiveX控件的零点认证的系统和方法

    公开(公告)号：US20130055369A1

    公开(公告)日：2013-02-28

    申请号：US13216388

    申请日：2011-08-24

    Applicant: Pawan Kumar ,  Rohit Gupta ,  Manoj Badola

    Inventor： Pawan Kumar ,  Rohit Gupta ,  Manoj Badola

    IPC: H04L9/32 ,  G06F15/16 ,  G06F21/00

    CPC classification number: G06F21/572 ,  G06F21/51 ,  G06F21/52 ,  H04L9/3247 ,  H04L63/0823 ,  H04W4/50

    Abstract: A system and method in one embodiment includes modules for verifying a digital signature of a Microsoft® ActiveX® control, identifying an executable file of the ActiveX control, authorizing the executable file as an updater configured to enable trust propagation, if the digital signature is from an authorized issuer, and installing the ActiveX control. More specific embodiments include hooking an exported function in the executable file and marking a thread calling the exported function as an updater. Hooking the exported function includes patching the executable function so that when the exported function is called during execution of the executable file, a second function is executed before the exported function is executed. Other embodiments include extracting a cabinet file wrapping the ActiveX control, parsing an information file in the cabinet file, and downloading additional components for installing the ActiveX control.

    Abstract translation: 一个实施例中的系统和方法包括用于验证Microsoft ActiveX控件的数字签名的模块，识别ActiveX控件的可执行文件，将可执行文件授权为配置为启用信任传播的更新器，如果数字签名来自 授权发行人，并安装ActiveX控件。 更具体的实施例包括将可导出的功能挂接在可执行文件中，并将一个线程称为导出的函数作为更新程序。 挂接导出的函数包括修补可执行函数，以便在执行可执行文件时调用导出函数时，在执行导出函数之前执行第二个函数。 其他实施例包括提取包装ActiveX控件的机柜文件，解析橱柜文件中的信息文件，以及下载用于安装ActiveX控件的附加组件。

    Process for the extraction of furostanolic saponins from fenugreek seeds
    56.
    发明授权
    Process for the extraction of furostanolic saponins from fenugreek seeds 有权
    从葫芦巴种子中提取呋喃维生素皂苷的方法

    公开(公告)号：US08217165B2

    公开(公告)日：2012-07-10

    申请号：US12665279

    申请日：2008-09-03

    Applicant: Pawan Kumar Goel

    Inventor： Pawan Kumar Goel

    IPC: C07H1/06 ,  C07H1/08

    CPC classification number: C07J71/0031 ,  A61K36/48

    Abstract: A novel, commercially viable process for the extraction of high purity (>70%), bioactive furostanolic saponins including protodioscin (>30%), from the seeds of fenugreek (Trigonella foenumgraecum) comprising essentially the steps of powdering of the natural material followed by a first extraction, an ion-exchange chromatographic purification and a second extraction using a novel composite solvent and drying of the product under defined conditions, the entire process being carried out at essentially neutral pH and low temperatures of less than 80° C.

    Abstract translation: 一种用于从葫芦巴（Trigonella foenumgraecum）的种子中提取高纯度（> 70％），包括原花青素（> 30％）的生物活性呋喃糖醇皂苷的新颖的商业上可行的方法，其基本上包括以下步骤：粉碎天然材料， 第一次萃取，离子交换色谱纯化和使用新型复合溶剂的第二次萃取，并在规定的条件下干燥产物，整个过程在基本上中性的pH值和低于80℃的低温下进行。

    NOVEL ANTIDIABETIC FUROSTANOLIC SAPONIN RICH (FSR) FRACTION FROM FENUGREEK SEEDS
    57.
    发明申请
    NOVEL ANTIDIABETIC FUROSTANOLIC SAPONIN RICH (FSR) FRACTION FROM FENUGREEK SEEDS 审中-公开
    来自蕨类植物的新型抗真菌SAP藜皂苷（FSR）

    公开(公告)号：US20120071427A1

    公开(公告)日：2012-03-22

    申请号：US13322460

    申请日：2010-05-28

    Applicant: Pawan Kumar Goel

    Inventor： Pawan Kumar Goel

    IPC: A61K31/7048 ,  A61P3/10

    CPC classification number: A61K36/48

    Abstract: The present invention discloses a novel anti-diabetic composition extracted from fenugreek seeds. The same comprises a furostanolic-saponin-rich fraction (>70%) with approximately 30% protodioscin as one of the bioactive components. Pre-clinical studies in rats indicated significant glucose lowering effect of the fraction (31.5%) as compared to control after two weeks of oral treatment. Clinical studies in human volunteers indicated suitability of a dosage form of 500 mg given once or twice daily as anti-diabetic agent either alone or in combination with standard, synthetic anti-diabetic drugs such as metformin and glipizide in controlling plasma glucose levels.

    Abstract translation: 本发明公开了从葫芦巴种子提取的新型抗糖尿病组合物。 其中含有富含富鲁丝酵素 - 富含皂苷的级分（> 70％），其中约30％原生质蛋白作为生物活性成分之一。 大鼠的临床前研究表明，两周口服治疗后，与对照组相比，该组分（31.5％）具有显着的葡萄糖降低作用。 人类志愿者的临床研究表明500mg给药剂量的适用性，每日给予一次或两次，作为抗糖尿病药，单独使用或与标准的合成抗糖尿病药物如二甲双胍和格列吡嗪组合以控制血浆葡萄糖水平。

Patent Agency Ranking